Autonomix Medical Return on Equity (ROE) Growth & History (AMIX)
Autonomix Medical's return on equity was −238.89% for fiscal 2026.
View full Autonomix Medical company overviewAutonomix Medical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | −238.89% | −93.79 pp |
| 2025 | 2025-03-31 | −145.10% | +227.87 pp |
| 2024 | 2024-03-31 | −372.97% | — |
Autonomix Medical quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2027 | 2026-06-30 | −60.24% | −16.13 pp |
| Q4 2026 | 2026-03-31 | −36.90% | +91.26 pp |
| Q3 2026 | 2025-12-31 | −43.46% | −0.87 pp |
| Q2 2026 | 2025-09-30 | −110.55% | −43.05 pp |
| Q1 2026 | 2025-06-30 | −44.11% | −2.32 pp |
| Q4 2025 | 2025-03-31 | −128.16% | +1389.40 pp |
| Q3 2025 | 2024-12-31 | −42.59% | — |
| Q2 2025 | 2024-09-30 | −67.50% | — |
| Q1 2025 | 2024-06-30 | −41.79% | — |
| Q4 2024 | 2024-03-31 | −1,517.56% | — |
Autonomix Medical return on equity trends
Between the periods ended 2024-03-31 and 2026-03-31, Autonomix Medical's return on equity increased from −372.97% to −238.89%, a change of +134.08 percentage points. The latest reported quarter, Q1 2027, shows −60.24%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Autonomix Medical source filings ↗